GR
Grace Therapeutics, Inc. (GRCE)
NASDAQ·Healthcare·Biotechnology
$2.21
+0.00%
Mkt Cap $55.53M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+81.0%
Consensus $4.00 vs current $2.21
NASDAQ·Healthcare·Biotechnology
$2.21
+0.00%
Mkt Cap $55.53M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
+81.0%
Consensus $4.00 vs current $2.21